Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CVS GroupCVSGF 91 Earnings per Share (Diluted) is $0.93 as of Dec. 2025. GuruFocus rates CVSGF with a GF Score™ of 91/100 and a GF Value™ of $17.16 (Fairly Valued). The stock has 5 warning signs investors should review. Among 506 Healthcare Providers & Services companies, CVS Group ranks worse than 68.77% on this metric.
CVS Group's EPS (Basic) for the
six
months ended in Dec. 2025 was $0.15.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.93.
CVS Group's EPS without NRI for the
six
months ended in Dec. 2025 was $0.54.
Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 was $1.11.
During the past 12 months, CVS Group's average EPS without NRIGrowth Rate was 12.70% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was -2.00% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 11.20% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 13.90% per year.
During the past 13 years, CVS Group's highest 3-Year average EPS without NRI Growth Rate was 43.40% per year. The lowest was -2.00% per year. And the median was 17.90% per year.
CVS Group (OTCPK:CVSGF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
CVS Group Earnings per Share (Diluted) Related Terms
CVS Group Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for CVS Group's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CVSGF vs HCA, THC, DVA: Earnings per Share (Diluted) Comparison
For the Medical Care Facilities subindustry, CVS Group's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CVS Group PE Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, CVS Group's PE Ratio distribution charts can be found below:
* The bar in red indicates where CVS Group's PE Ratio falls into.
CVS Group Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
CVS Group's Earnings Per Share (Diluted) for the fiscal year that ended in Jun. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $0.93 mean?
CVS Group (CVSGF) has a Earnings per Share (Diluted) of $0.93 as of Dec. 2025. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on CVS Group and its competitors. According to the industry distribution chart, CVS Group ranks #348 out of 506 companies in the Healthcare Providers & Services industry, placing it in the top 68.8%.
Is CVS Group's Earnings per Share (Diluted) too high?
CVS Group's current Earnings per Share (Diluted) is $0.93. The Healthcare Providers & Services industry median Earnings per Share (Diluted) is 11.00. CVS Group's value of $0.93 is 91.5% below this industry median. Based on the distribution chart, CVS Group ranks #348 out of 506 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, CVS Group has a GF Score™ of 91/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does CVS Group's Earnings per Share (Diluted) compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, CVS Group ranks #348 out of 506 companies for Earnings per Share (Diluted). This places CVS Group in the lower half of its industry. The industry median Earnings per Share (Diluted) is 11.00. CVS Group's value of $0.93 is 91.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Healthcare Providers & Services company?
The median Earnings per Share (Diluted) among Healthcare Providers & Services companies is 11.00, based on 506 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CVS Group's current Earnings per Share (Diluted) of $0.93 is 91.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on CVS Group and its competitors. For the Healthcare Providers & Services industry, the median Earnings per Share (Diluted) is 11.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVS Group's current Earnings per Share (Diluted) is $0.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVS Group stock overvalued right now?
Based on GuruFocus' analysis, CVS Group (CVSGF) is currently considered Fairly Valued. The stock's GF Value™ is $17.16, compared to a current price of $16.60 — trading 3.3% below its estimated fair value. The current Earnings per Share (Diluted) is $0.93 and 91.5% below the Healthcare Providers & Services industry median of 11.00. CVS Group's overall GF Score™ is 91/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For CVS Group (CVSGF), the current Earnings per Share (Diluted) is $0.93 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CVS Group (CVSGF) Overvalued in 2026?
Based on GuruFocus' analysis, CVS Group stock appears to be undervalued.
The current stock price of $16.60 is trading 3.3% below its estimated GF Value™ of $17.16.
GuruFocus considers CVS Group to be Fairly Valued.
Key valuation signals for CVSGF:
Earnings per Share (Diluted): $0.93
GF Value™: $17.16 vs. price of $16.60 (3.3% below fair value)
Industry Position: 91.5% below the Healthcare Providers & Services median (#348 of 506)
No single metric tells the full story. See the CVSGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CVS Group PLC is a veterinary service provider in the United Kingdom. The group operates through three business divisions: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. The veterinary practice segment generates the majority of the revenues. The company facilitates its veterinary services through its diagnostics, laboratory reports, and pet cremation services. It also offers retail pharmacy through Animed Direct. Geographically, it generates the majority of its revenue from the United Kingdom and also operates in Australia.
91GF Score
Get the complete analysis for CVSGF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CVSGF has been successfully added to your 
